Voyager Therapeutics stock soars on Pfizer deal
October 06, 2021 at 11:24 AM EDT
Shares of Cambridge biotech Voyager Therapeutics Inc. are up more than 60% on the news that the company inked a $630 million licensing deal with Pfizer Inc.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.